Tatva Chintan Pharma Chem Limited (TATVA) — Cash Flow Quality Index
Tatva Chintan Pharma Chem Limited (TATVA) has a Cash Flow Quality Index of 3.81x as of December 2023. Operating cash flow of Rs131.66 Million exceeds net income of Rs34.55 Million, indicating high earnings quality where cash backs reported profits. Explore TATVA cash flow conversion to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Tatva Chintan Pharma Chem Limited Cash Flow Quality Index (2018–2025)
Historical Cash Flow Quality Index for Tatva Chintan Pharma Chem Limited across 8 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Tatva Chintan Pharma Chem Limited (TATVA) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Tatva Chintan Pharma Chem Limited (2018–2025)
Year-by-year earnings quality comparison for Tatva Chintan Pharma Chem Limited. For live market cap and the full company financial profile, see TATVA stock market capitalisation.
| Year | Quality Index | Operating CF (INR) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 4.32x | Rs246.71 Million | Rs57.13 Million | ▲ +33.7% |
| 2024 | 3.23x | Rs980.44 Million | Rs303.54 Million | ▲ +420.6% |
| 2023 | 0.62x | Rs277.83 Million | Rs447.79 Million | ▲ +217.0% |
| 2022 | 0.20x | Rs203.78 Million | Rs1.04 Billion | ▼ -51.2% |
| 2021 | 0.40x | Rs243.19 Million | Rs606.96 Million | ▼ -24.7% |
| 2020 | 0.53x | Rs253.12 Million | Rs475.97 Million | ▲ +98.0% |
| 2019 | 0.27x | Rs73.56 Million | Rs273.93 Million | ▼ -68.3% |
| 2018 | 0.85x | Rs104.12 Million | Rs122.89 Million | — |